Chemoinformaics analysis of pseudo ginsenoside f 11
| Molecular Weight | 801.024 | nRot | 7 |
| Heavy Atom Molecular Weight | 728.448 | nRig | 37 |
| Exact Molecular Weight | 800.492 | nRing | 7 |
| Solubility: LogS | -3.314 | nHRing | 3 |
| Solubility: LogP | 3.271 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 128 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 0 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 42 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 0 |
| nHA | 14 | APOL | 129.377 |
| nHD | 9 | BPOL | 80.9109 |
| QED | 0.166 |
| Synth | 6.084 |
| Natural Product Likeliness | 3.053 |
| NR-PPAR-gamma | 0.048 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.99 |
| Pgp-sub | 0.229 |
| HIA | 0.406 |
| CACO-2 | -5.588 |
| MDCK | 0.0000701 |
| BBB | 0.021 |
| PPB | 0.566488 |
| VDSS | 0.243 |
| FU | 0.122064 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.186 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.694 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.025 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.079 |
| CYP3a4-inh | 0.067 |
| CYP3a4-sub | 0.079 |
| CL | 0.752 |
| T12 | 0.654 |
| hERG | 0.175 |
| Ames | 0.057 |
| ROA | 0.15 |
| SkinSen | 0.729 |
| Carcinogencity | 0.005 |
| EI | 0.009 |
| Respiratory | 0.974 |
| NR-Aromatase | 0.628 |
| Antiviral | Yes |
| Prediction | 0.843799 |